-
Shaping the future of therapeutic antibodies with Digital SPR
We spent a week with innovators of antibody therapeutics to learn how we can enhance development from bench to bedside By Mike Piazza, Associate Director of Applications Development We recently had th...
-
The future of biosimilars: How emerging technologies are paving the way
Next-generation methods that streamline biosimilar expression and characterization are imperative to lowering the cost of development and maximizing market growth. Biosimilars have delivered on their ...
-
Keeping up with viral evolution: How SPR streamlines prevention and treatment of influenza
Our next generation SPR platforms provide high-quality data and streamline research workflows to give you an edge in the fight against influenza. Influenza viruses cause respiratory infections in huma...